MedPath

Brain Effects of Opiate Agonist and Antagonist

Phase 4
Completed
Conditions
Chronic Low-back Pain
Interventions
Registration Number
NCT04342130
Lead Sponsor
University of Rochester
Brief Summary

This study will look at the short-term effect of morphine on brain response to food.

Detailed Description

Chronic low back pain patients and healthy controls will be recruited for this study. Participants' brain will be scanned at baseline and then again on a different day after the administration of an oral dose of 30 mg morphine in an open label design. Participants will receive morphine 60 minutes prior to the start of the second scanning session. The brain scans will include structural scans, functional scans at rest and functional scans during the ingestion of a highly caloric drink.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
10
Inclusion Criteria
  • Healthy participants
  • Patients in pain: suffering from persistent pain more days than not, 3/10 in intensity on a numerical rating scale, for at least 6 weeks or more.
Exclusion Criteria
  • Any DSM diagnosis
  • diabetes
  • food allergies
  • lactose intolerance
  • participants seeking to quit smoking or to lose weight
  • participants on any psychotropic medication including opiate based analgesics (e.g. oxycodone, methadone, suboxone)
  • pregnant or nursing women
  • pacemaker or other implanted electrical devices
  • Participants with a past history of head trauma or seizures
  • Any past history of illegal drug or alcohol misuse
  • Participants who cannot undergo an MRI scan.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
All ParticipantsMorphinePeople with low back pain who were given and oral dose of 30 mg morphine.
Primary Outcome Measures
NameTimeMethod
Mean Change in Subcortical Brain Structure Volumebaseline to 1 hour

Magnetic Resonance Imaging (MRI) scanning was performed to collect brain volume measurements in cc. There were 4 different areas of the brain that were analyzed.

Change in Brain Response to Highly Caloric Drinkbaseline to 1 hour

Participants received a highly caloric drink and a tasteless solution during a functional MRI scanning session. A general linear model was used to generate the magnitude of the fit for each type of stimuli and differences between the fits were calculated. A within subject analysis approach was used to calculate the effect of an acute dose of morphine on brain response to the highly caloric drink. Participants contributed beta values that were averaged across subjects and based on the average and standard deviation, the software, FSL, calculated Z = 4.38. This value indicates 4.38 standard deviations away from the mean in a distribution with a mean of zero and standard deviation of 1, which is the definition of the Gaussian curve (Z-distribution). It is scientifically not valid to say there is a higher or lower brain response. A Z-score = 0 means no change from baseline in brain response; a Z-score different from zero indicates a change from baseline after the ingestion of morphine.

Mean Change in Resting Brain Activity in the Nucleus Accumbensbaseline to 1 hour

Participants were scanned at rest during a functional MRI session. The resting brain activity was measured as the Power spectral density slow-4 frequency band. Data collected in the frequency range 0 and 0.5 Hertz was analyzed. We examined the power spectral density in the range of 0.027 to 0.073 Hertz. The mean change is expressed as arbitrary units after a Fourier transformation of the data which cancels out the units. The mean change ranges from 0 to 175. The higher the number the more energy within that frequency band.

Secondary Outcome Measures
NameTimeMethod
Mean Change in Back Pain Intensitybaseline to 1 hour

Pain was rated using a visual analog scale ranging from 0-100 with 100 indicating the worst imaginable pain ever.

Trial Locations

Locations (1)

Yale University

🇺🇸

New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath